ISRAEL’S MEDICAL ACHIEVEMENTS
Protein protects brain against DNA damage. (TY Eli) Scientists at Israel’s Ben Gurion University have discovered that the protein SIRT6 is key to repairing DNA damage that causes neurodegenerative brain diseases. SIRT6 was almost completely absent in Alzheimer’s disease patients. http://www.jpost.com/Business-and-Innovation/Health-and-Science/Israeli-scientists-find-likely-cause-of-neurodegenerative-diseases-490134
http://www.cell.com/cell-reports/abstract/S2211-1247(17)30325-X
New understanding about Parkinson’s. Researchers from Israel’s Technion and Harvard have a new theory on how Parkinson’s disease develops. The responsible toxic protein alpha-synuclein doesn’t spread like an infection but accumulates throughout the body. It could change the way the neurological disease is treated.
https://www.israel21c.org/harvard-technion-study-suggests-new-parkinsons-theory/
http://www.cell.com/trends/neurosciences/abstract/S0166-2236(16)30145-X
Removing lung tumors using AR. Israel’s Body Vision Medical has integrated CT scans with X-rays to help surgeons remove small, early-stage lung-cancer tumors. Pre-surgery 3D CT images are overlaid with 2D X-ray images during the operation to produce high-resolution Augmented Reality maps of the tumors in real-time.
http://www.globes.co.il/en/article-body-vision-maps-lung-cancer-1001187492
http://www.bodyvisionmedical.com/
Easier removal of colon polyps. Israel’s Tandem Technologies has developed Tandem Snare – a device for precise removal and retrieval of polyps in the colon. Tandem’s CEO Noam Hassidov described the device on ILTV. https://www.youtube.com/embed#3IRkVWCVwYA?rel=0
http://trendlines.com/portfolio/tandem-technologies/
Safe stitches. I reported previously (Jan 29) about Israel’s Gordian Surgical and its safe suturing (stitching) system to assist minimally-invasive surgery. Gordian’s Doni Mayerfield was interviewed recently on ILTV.
https://www.youtube.com/embed/bzD2DDuXGPI?rel=0
Another cure for pelvic prolapse. Israel’s Escala Medical has developed what it describes as “the only non-surgical, incision-free 20-minute solution for patients suffering pelvic prolapse.” It is targeting FDA approval by the end of 2017. (I reported on a similar solution previously.)
https://www.israel21c.org/first-ever-incision-free-fix-for-pelvic-organ-prolapse/
https://www.youtube.com/embed/r_livY0vlIQ?rel=0 http://trendlines.com/portfolio/escala-medical/
Cartilage regeneration aims for FDA approval. Israeli bone regeneration biotech CartiHeal has raised $18.3 million to fund a trial that will help it achieve US FDA approval for its cartilage regeneration technology. CartiHeal already has CE (European) marketing approval.
http://www.globes.co.il/en/article-israel-bone-regeneration-co-cartiheal-raises-183m-1001187527
Cancer biotech launches on NASDAQ. Israel’s UroGen has three treatments for the treatment of cancers of the urinary system (bladder and kidneys). It has just raised $58.2 million on NASDAQ. UroGen’s MitoGel treatment for Upper Tract Urothelial Carcinoma has received Orphan status from the US FDA.
http://www.globes.co.il/en/article-urogen-pharma-raises-582m-in-nasdaq-ipo-1001187475
https://www.youtube.com/embed/6aBvLhlUxh0?rel=0
UK medical magazine publicizes Israeli achievements. Newsletter readers may remember (Oct 2014) when UK Lancet editor Professor Richard Horton visited Rambam hospital after writing an anti-Israel article. In his latest publication, Horton has made a complete turnaround, publishing 15 positive Israeli medical articles.
http://www.ynetnews.com/articles/0,7340,L-4959260,00.html
http://www.thelancet.com/series/health-in-israel
Israel’s first “green” hospital. (TY Eli) Jerusalem’s Herzog Medical Center, Israel’s foremost center for geriatric, respiratory, mental health and psycho-trauma treatment, is opening Israel’s first environmentally-friendly pavilion. The 270-bed 8-floor facility includes a 200-bed underground emergency hospital.
http://www.ynetnews.com/articles/0,7340,L-4958694,00.html
Personalized cancer treatment. Israel’s GeneSort detects specific genetic mutations linked to various types of cancer. Oncologists can then adapt treatments to the patient’s specific genetic mutations, dramatically improving outcomes. GeneSort has just been acquired by Hong Kong investment fund AID Partners for $23 million. http://www.globes.co.il/en/article-aid-partners-buys-israels-genesort-for-23m-1001187888
https://www.genesort.com/about-us
Iraqi boy gets bovine heart valve. Israeli surgeon Sagi Assa from Save A Child’s Heart worked together with his former mentor Dr Stephan Schubert from Germany to implant an artificial heart valve into 11-year-old Iraqi-Kurdish boy Marwan Ghazi Ali. The valve was made from the jugular vein of an Australian cow.
http://www.jpost.com/Israel-News/German-and-Israeli-doctors-partner-on-Iraqi-childs-heart-surgery-490163